# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch - Amoxicillin-clavulanate potassium dry suspension

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/265171de-990e-4d1a-b925-3ec460cb0a91/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch published June 17, 2021. Drug: Amoxicillin-clavulanate potassium dry suspension. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 5, 2021)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin-clavulanate potassium dry suspension
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/3bc2a5d2-1c14-4c56-9122-3363685b4c1d/